Stay updated on Psilocybin vs Niacin for Depression Clinical Trial

Sign up to get notified when there's something new on the Psilocybin vs Niacin for Depression Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Psilocybin vs Niacin for Depression Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The page's revision line was updated from v3.6.2 to v3.6.3, signaling a software or content update to the study record without changing the study data.
    Difference
    0.1%
    Check dated 2026-07-05T11:56:48.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The page shows a revision label updated from v3.6.0 to v3.6.2, indicating a newer release of the site’s software. This appears to be a backend/UI patch without changes to the study information.
    Difference
    0.1%
    Check dated 2026-06-28T06:15:40.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    Recruitment status is updated to indicate the study is no longer enrolling, and new guidance sections are added along with a revision note; the Intervention/Treatment heading formatting was adjusted.
    Difference
    0.7%
    Check dated 2026-06-14T05:28:17.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The page shows a new revision tag, v3.5.5, indicating a new site build; this reflects backend updates rather than changes to study information.
    Difference
    0.1%
    Check dated 2026-06-07T02:11:05.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    The page’s revision tag was updated from v3.5.3 to v3.5.4, signaling a minor site update. This change does not modify the study details or how the page operates for users.
    Difference
    0.1%
    Check dated 2026-05-16T09:24:05.000Z thumbnail image
  8. Check
    72 days ago
    Change Detected
    Summary
    Adds the PSIL201-LTFU long-term follow-up study details, including its title, observational design, dosing context (psilocybin vs niacin), sample size (26), site and sponsor (Usona Institute), and the study director. It also specifies the primary outcome (MADRS) and the planned timepoints, clarifying how this follow-up study is structured.
    Difference
    1%
    Check dated 2026-05-09T03:20:12.000Z thumbnail image

Stay in the know with updates to Psilocybin vs Niacin for Depression Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Psilocybin vs Niacin for Depression Clinical Trial page.